Asymmetrical Versus Conventional High-flow Nasal Cannula in Acute Respiratory Failure
NCT: NCT06204276 · COMPLETED
Brief Summary
The goal of this randomized crossover physiological study is to evaluate the physiologic effects of asymmetrical nasal cannula and conventional nasal cannula in patients with acute respiratory failure. The main questions it aims to answer are: * Does the asymmetrical high-flow nasal cannula reduce the diaphragm and parasternal intercostal work activity of breathing measured by ultrasound compared to conventional high-flow nasal cannula? * What is the effect of the asymmetrical high-flow nasal cannula on breathing pattern, gas exchange, and hemodynamic variables compared to conventional high-flow nasal cannula? Participants will received asymmetrical high-flow nasal cannula or conventional high-flow nasal cannula at a flow rate of 40 and 60 L/min in a random order.
Frequently Asked Questions
What is Asymmetrical Versus Conventional High-flow Nasal Cannula in Acute Respiratory Failure?
Asymmetrical Versus Conventional High-flow Nasal Cannula in Acute Respiratory Failure is a clinical trial registered under NCT06204276. Current status: COMPLETED.
What is the status of NCT06204276?
The current status of NCT06204276 (Asymmetrical Versus Conventional High-flow Nasal Cannula in Acute Respiratory Failure) is: COMPLETED.
When did Asymmetrical Versus Conventional High-flow Nasal Cannula in Acute Respiratory Failure start?
Asymmetrical Versus Conventional High-flow Nasal Cannula in Acute Respiratory Failure started on 2024-01-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.